ASCO20 virtual annual meeting: Editors’ highlights

Written by Rachel Jenkins, Future Science Group

 

The American Society for Clinical Oncology (ASCO) annual meeting took place in a virtual format on 29–31 May 2020. Over the three days, exciting work was presented from across the globe, to continue to advance the oncology field and patient outcomes.

Oncology Central, Future Oncology, The Nanomed Zone and Infectious Diseases Hub have collated our Editors’ highlights in the above ‘Editors’ coffee chat’. Let us know your thoughts on Twitter @OncologyCentral.

Want regular meeting updates straight to your inbox? Become a member of Oncology Central.

 

ASCO news

TERAVOLT provides insight into outcomes for cancer patients who develop COVID-19

Immunotherapy treatment shows significant improvements in metastatic colorectal cancer

New data suggests feasibility of precision medicine in pediatric cancer

ADAURA trial demonstrates potential using osimertinib for late-stage NSCLC

Hydroxychloroquine and azithromycin combination treatment linked to greater mortality in cancer patients with COVID-19

Could a liquid biopsy guide prostate cancer treatment decisions?

ASCO expert opinions

Immunotherapy combinations for non-small-cell lung cancer, an interview with Grace Dy

Completing the circle for EGFR-directed therapies

Results from the MAGENTA trial, an interview with Elizabeth Swisher

Social media

For the latest conference news, visit our Events Coverage page now!